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Plasmodium pseudo-tyrosine 
Kinase-like binds PP1 and 
SERA5 and is exported to host 
erythrocytes
Bénédicte Gnangnon1, Aline Fréville1, Katia Cailliau2, Catherine Leroy3, Caroline De Witte1, 
David tulasne3, Alain Martoriarti2, Vincent Jung4, Ida Chiara Guerrera4, sabrina Marion1, 
Jamal Khalife1 & Christine Pierrot  1
Pseudokinases play key roles in many biological processes but they are poorly understood compared to 
active kinases. Eight putative pseudokinases have been predicted in Plasmodium species. We selected 
the unique pseudokinase belonging to tyrosine kinase like (TKL) family for detailed structural and 
functional analysis in P. falciparum and P. berghei. The primary structure of PfpTKL lacks residues 
critical for kinase activity, supporting its annotation as a pseudokinase. The recombinant pTKL 
pseudokinase domain was able to bind ATP, but lacked catalytic activity as predicted. The sterile alpha 
motif (SAM) and RVxF motifs of PfpTKL were found to interact with the P. falciparum proteins serine 
repeat antigen 5 (SERA5) and protein phosphatase type 1 (PP1) respectively, suggesting that pTKL has 
a scaffolding role. Furthermore, we found that PP1c activity in a heterologous model was modulated 
in an RVxF-dependent manner. During the trophozoite stages, PbpTKL was exported to infected 
erythrocytes where it formed complexes with proteins involved in cytoskeletal organization or host 
cell maturation and homeostasis. Finally, genetic analysis demonstrated that viable strains obtained 
by genomic deletion or knocking down PbpTKL did not affect the course of parasite intra-erythrocytic 
development or gametocyte emergence, indicating functional redundancy during these parasite stages.
Malaria remains one of the most life-threatening parasitic diseases in the world, with 219 million cases leading 
to an estimated 435,000 deaths worldwide in 20171. Among the Plasmodium species that infect humans, P. falci-
parum is the most virulent and is responsible for more than 90% of deaths, mostly in African children less than 5 
years old. Thanks to preventative measures such as bed nets and treatments mainly involving artemisinin-based 
combination therapy (ACT), the global incidence of malaria fell by 38% between 2010 and 20162,3. However, the 
rapid spread of ACT-resistant Plasmodium strains in South-East Asia is alarming, and innovative antimalarial 
strategies are therefore needed4–6.
The life cycle of Plasmodium species is complex because the parasite infects two hosts and progresses through 
various stages of development that are replicative, invasive or involved in sexual reproduction7,8. To sustain devel-
opment and respond to environmental changes, the parasite uses post-translational modifications (PTMs) for 
the dynamic modulation of protein function, in many cases phosphorylation9. This reversible modification is 
catalyzed by protein kinases and the phosphate groups are removed by protein phosphatases. Phosphoproteomics 
approaches have revealed that kinases and phosphatases play key roles in cell growth, division, motility, invasion 
and communication with host cells during the Plasmodium life cycle10–13. The essential role of these enzymes 
has also been demonstrated using phosphatase and kinase inhibitors14–16, most of which are deleterious to the 
parasite17. Reverse genetics has helped to decipher the role of several of these enzymes at each developmental 
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stage12,18,19. These studies, as well as the more detailed characterization of specific enzymes, have improved our 
understanding of Plasmodium signal transduction pathways20.
Although phosphorylated tyrosine residues can be detected in the late Plasmodium development stages13, 
the parasite kinome is mainly composed of serine/threonine (S/T) kinases21. Hanks-type S/T kinases are 
membrane-bound or cytoplasmic enzymes that share common features22, including a 12-subdomain signature in 
the catalytic domain required for kinase activity23,24. Active kinases take part in regulatory networks that allow the 
integration of signals by controlling protein structure and activity. Enzymes that lack one of the catalytic residues 
required for kinase activity are classified as pseudokinases25. They constitute 10% of the mammalian kinome and 
fulfil a plethora of biological roles, depending on their subdomain composition and their ability to bind ATP and/
or divalent ions26,27. They can introduce PTMs, either as active kinases if they have evolved compensatory mecha-
nisms to overcome the lack of one or more key subdomains (e.g., CASK28, Haspin29, WNK130, and other examples 
that have been reviewed31,32) or as AMPylation catalyzers33, demonstrating the functional versatility of kinase 
domains. Some pseudokinases also play a role in cell signaling. They can notably function as protein–protein 
interaction platforms or allosteric regulators of various enzymes, including kinases34, or of protein trafficking and 
subcellular localization35. Their importance in metazoan cell homeostasis is highlighted by their role in diseases, 
including cancer36.
In apicomplexan parasites, most pseudokinases are poorly characterized, but the highly polymorphic ROP5 
family in Toxoplasma gondii has been studied in detail37. TgROP5 binds ATP but lacks kinase activity in vitro, 
probably due to the absence of a catalytic aspartate residue in subdomain VI. However, the conservation of this 
non-canonical motif is necessary for parasitic virulence37. TgROP5 forms a complex with the kinases TgROP17 
and TgROP18, causing the synergistic neutralization of host immunity-related GTPases (IRGs), favoring infec-
tion by protecting the parasite from cell-mediated clearance38,39. Reverse genetics has been used to confirm that 
TgROP5 is required for parasite virulence in genetically divergent strains40, revealing that parasite pseudoen-
zymes can play essential roles at the host–pathogen interface.
The Plasmodium kinome was initially predicted to include eight pseudokinases41, five of which are probably 
essential for the intra-erythrocytic development of the parasite19. Here, we report the characterization of the 
unique Plasmodium pseudo-tyrosine kinase-like (pTKL) protein, previously named TKL542. We evaluated its 
potential for kinase activity, characterized its interactions to establish its molecular function, and investigated its 
biological role using different knockout and knock-down approaches.
Results
PfpTKL transcript sequencing and protein annotation. To confirm PfpTKL transcription, we per-
formed overlapping PCR on reverse transcribed Pf3D7 total RNA using primer pairs derived from the pre-
dicted PF3D7_1106800 sequence (Supplementary Fig. S1 and Table S1). We analyzed 6–12 sequences amplified 
from two independent reverse transcribed RNA preparations for each of the eight transcript fragments (length 
600–1200 bp). The deduced amino acid sequence (1483 residues) was compared to the PlasmoDB43 predicted 
sequence. Both sets of data were identical with the exception of minor substitutions that did not affect the overall 
annotation (Supplementary Fig. S1).
More detailed analysis revealed the presence of multiple domains (Figs 1 and 2; summarized in Table 1 and 
showed in Fig. 3a). From the N-terminus to the C-terminus, we identified two membrane occupation recognition 
nexus (MORN) motifs (Fig. 2a), one classical sterile alpha motif (SAM) predicted to bind proteins (Fig. 2c,d; 
Supplementary Fig. S5), one Bruton’s tyrosine kinase (BTK)-like N-terminal lobe, designated as BTK-like domain 
(Fig. 1b; Supplementary Fig. S3) and one kinase domain (KD; Fig. 1a). We found that the KD lacks key residues 
required for ATP stabilization and phosphoryl transfer, confirming that PfpTKL is a pseudokinase (Fig. 1a). Two 
putative RVxF motifs, described as protein phosphatase 1 (PP1) catalytic subunit PP1c binding motifs44, were also 
identified (Fig. 2b). RVxF1 was localized to the C-terminal side of the SAM whereas RVxF2 was localized within 
the KD. Low-complexity regions enriched in asparagine, lysine or serine were identified between the predicted 
folded domains.
Phylogenetic classification of PfpTKL. We constructed a phylogenetic tree comprising PfpTKL 
homologs and a RAF1 outgroup. The tree with the highest log likelihood is presented in Fig. 3c. The topology of 
the tree reflects the general classification of eukaryotes45, with the apicomplexa clustering together in one clade 
(Alveolata), as well as the Stramenopile Thraustotheca clavata and the Metazoa (RAF1 outgroup). Within the 
alveolates, Toxoplasma, Eimeria, Neospora, Hammondia and Besnoitia (Eucoccidia) cluster in one clade, as well 
as Plasmodium (Haemosporida). Gregarina niphandrodes forms a monophyletic clade within the alveolates. This 
classification reflects the molecular structure of all of the proteins displayed in Fig. 3b. Stramenopile proteins 
contain only one KD. All alveolate proteins contain two MORN motifs at their N-terminus (one atypical) and at 
least one KD at their extreme C-terminus. Eucoccidia proteins occasionally contain a SAM domain in addition to 
MORN motifs and a KD. Eimeria maxima stands out with two KDs, but nevertheless clusters with other Eimeria 
proteins. The Plasmodium clade members are the most complex in terms of molecular composition. In addition 
to the domains listed for Eucoccidia, they also contain at least one RVxF motif in their KD and a BTK-like domain 
upstream of the C-terminal KD. Interestingly, the P. falciparum, P. praefalciparum, P. reichenowi, P. billcollinsi 
and P. blacklocki sequences clustered together as previously described46 and stand out among all Plasmodium 
sequences given the presence of a second RVxF motif located downstream of the SAM domain. Importantly, this 
analysis revealed that pTKL is specific to certain apicomplexan species.
The PfpTKL KD binds ATP but is catalytically inactive. The PfpTKL KD was produced as a recom-
binant protein named pTKL_KD_WT (Supplementary Fig. S6) and its ability to bind ATP was evaluated using 
a pull-down assay based on ATP-agarose beads (Fig. 4a). To determine whether the ATP-binding activity of 
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PfpTKL KD is cation dependent, the amino acid triplet 1290DFG1292 in subdomain VII was mutated to 1290GFE1292 
(pTKL_KD_DG) because this motif is required for cation binding to stabilize ATP and favor phosphate group 
transfer. The pTKL_KD_DG mutant retained its ability to bind ATP (Fig. 4a) indicating that PfpTKL belongs to 
the class 2 (nucleotide-only binding) pseudokinases26.
Next, we tested the catalytic activity of pTKL_KD_WT and pTKL_KD_DG using γ33P-ATP and three differ-
ent substrates: myelin basic protein (MBP), P. falciparum extracts and erythrocyte extracts (Fig. 4b). The positive 
control JNK1 displayed kinase activity against both MBP and the P. falciparum extracts, confirming the assay was 
working correctly, but neither pTKL_KD_WT nor pTKL_KD_DG were active against any substrate (Fig. 4b). 
To determine the reason for inactivity, we mutated N1272 back to a canonical phosphate group-transferring sub-
domain VIB aspartate (pTKL_KD_ND), but this mutant remained inactive despite retaining the ability to bind 
ATP (Fig. 4a,b).
Finally, we conducted a luminescence assay in the presence of MBP, which confirmed the ability of JNK1 
to hydrolyze ATP whereas pTKL_KD_WT, pTKL_KD_ND and pTKL_KD_DG lacked such activity (Fig. 4c, 
Supplementary Table S4).
Collectively, these experiments showed that the PfpTKL pseudo-KD was able to bind ATP but did not display 
any kinase activity.
PfpTKL RVxF1 and RVxF2 bind PfPP1c in vitro but only RVxF2 is functional in Xenopus laevis 
oocytes. The ability of the PfpTKL RVxF1 and RVxF2 motifs to bind the PfPP1 catalytic subunit (PfPP1c) 
a
b
 
 
                                       Domain I  j                                     Domain II                                    Domain III          Domain IV                                                                   Domain V   k        
PF3D7_1106800 prot. AA numbering   1134       1144       1154       1163       1173       1183       1193       1203       1213       1223  
                  ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....|   
PF3D7_1106800     DNHIYCNNIY DHHKNTSLNS KEQNTDHNIE QINECNKYA- SETKYNIKKS NLKNNIISHK NFQKCNQIQM NQPYTFPPYQ KELSSYLKNE KIKRKRKVLF  
Hs_RAF1_KD        VMLSTRIGSG SFGTVYKGKW HG---DVAVK ILKVVDPTP- EQFQAFRNEV AVLRKTRHVN ILLFMGYMTK D-NLAI---- --VTQWCEGS S-------LY  
Hs_BTK_KD         LTFLKELGTG QFGVVKYGKW RGQY-DVAIK MIKEGSMSE- DE---FIEEA KVMMNLSHEK LVQLYGVCTK QRPIFI---- --ITEYMANG C-------LL  
Hs_RIPK1_KD       FLESAELDSG GFGKVSLCFH RTQG-LMIMK TVYKGPNCI- EHNEALLEEA KMMNRLRHSR VVKLLGVIIE EGKYSL---- --VMEYMEKG N-------LM  
Hs_PKAc_KD        FERIKTLGTG SFGRVMLVKH KETGNHYAMK ILDKQKVVKL KQIEHTLNEK RILQAVNFPF LVKLEFSFKD NSNLYM---- --VMEYVPGG E-------MF  
  
                                                                                                                                                             Domain VIA     Domain VIB                            Domain VII 
PF3D7_1106800 prot. AA numbering   1233       1243       1253       1263       1273       1283       1293       1303       1313       1323  
                  ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....|  
PF3D7_1106800     SYLKTHIHFN SQQINDQHNR LSVQKIMKII TDVTLACTYL EKEKMSPINL KPTNILLDES LNAKISDFGI SKIENCLDMN IDYSYKISSN SVIKINKKEY  
Hs_RAF1_KD        KHLH------ -----VQETK FQMFQLIDIA RQTAQGMDYL HAKNIIHRDM KSNNIFLHEG LTVKIGDFGL ATV------- ---------- ------KSRW  
Hs_BTK_KD         NYLR------ -----EMRHR FQTQQLLEMC KDVCEAMEYL ESKQFLHRDL AARNCLVNDQ GVVKVSDFGL ---------- ---------- -------SRY  
Hs_RIPK1_KD       HVLK------ ----AEMSTP LSVKG--RII LEIIEGMCYL HGKGVIHKDL KPENILVDND FHIKIADLGL ASF------- ---------- -------KMW  
Hs_PKAc_KD        SHLR-----R IGRFSEPHAR FYAAQ----- --IVLTFEYL HSLDLIYRDL KPENLLIDQQ GYIQVTDFGF AKR------- ---------- ----VKGRTW  
 
                                                                                                                                                                                                    Domain VIII                                         Domain IX                   Domain X 
PF3D7_1106800 prot. AA numbering   1333       1343       1353       1363       1371       1381       1389       1399       1408       1418  
                  ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....|  
PF3D7_1106800     EQKKAKKIKI VNKNNNDLLY LYDHNNNVYK YNTQYIDVTY NNSYPS--IF YWTPPEILRG KKN--KKFYS DIYAFGIILW EMLS-NDIPY NYPFASHIMA  
Hs_RAF1_KD        SG-------- ---------- ---------- ------SQQV EQPTGS---V LWMAPEVIRM QDNNPFSFQS DVYSYGIVLY ELMT-GELPY SHINNRDQII  
Hs_BTK_KD         VL-------- ---------- ---------- ------DDEY TSSVGSKFPV RWSPPEVLMY SK---FSSKS DIWAFGVLMW EIYSLGKMPY ERFTNSETAE  
Hs_RIPK1_KD       SK-------L NNEEHNEL-- ---------- ---REVDGTA KKNGGT---L YYMAPEHLND VNA-KPTEKS DVYSFAVVLW AIFA-NKEPY ENAICEQQLI  
Hs_PKAc_KD        TL-------- ---------- ---------- ---------- ---CGT---P EYLAPEIILS KG---YNKAV DWWALGVLIY EMAA-GYPPF FADQPIQIYE  
 
                                                                                                                                                    Domain XI    
PF3D7_1106800 prot. AA numbering   1424       1432       1442       1452       1462       1472       1482                    
                  ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| . 
PF3D7_1106800     VVG----YAN EELS--FNNI PVSIQSLIKA CVNRNKYKRP TFEHILKTIS TLYQKANTKV EDALISFMDG T 
Hs_RAF1_KD        FMV-GRGYAS PDLSKLYKNC PKAMKRLVAD CVKKVKEERP LFPQILSSIE LL-------- ---------- - 
Hs_BTK_KD         HIAQGLRLYR PHLA------ SEKVYTIMYS CWHEKADERP TFKILLSNIL DVM------- ---------- - 
Hs_RIPK1_KD       MCI--KSGNR PDVDDITEYC PREIISLMKL CWEANPEARP TFPGIEEKFR PFY------- ---------- - 
Hs_PKAc_KD        KIVSGKVRFP SHFS------ -SDLKDLLRN LLQVDLTKR- -FGNLKNGVN DIKNH----- --------KW F 
PF3D7_1106800 AA posion    
                      
Homo sapiens  Hs_PKAc_Nlobe    
Homo sapiens  Hs_BTK_Nlobe     
P. falciparum  PF3D7_1106800    
P. reichenowi PRCDC_1105300    
P. knowlesi  PKNH_0904400     
P. malariae  PmUG01_09016400  
P. ovale  PocGH01_09013500 
P. gallinaceum  PGAL8A_00334100  
P. berghei  PBANKA_0940100   
P. yoelii   PYYM_0941700     
P. chabaudi  PCHAS_0904200    
P. vivax PVX_091015       
        841        851        860        868        878        888        895       905 
....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| 
GTGSFGRVM- -LVKHKETGN HYAMKILDKQ KVV--KLKQI EHTLNEKRIL QAVNFPFLVK LEFSFKDNSN LYMVMEYVPG 
GTGQFGVVKY GKWRGQY--- DVAIKMIKEG SMSEDEFIEE AKVMMN---L SHEKLVQLYG VCTKQR---P IFIITEYMAN 
---KYKKMKS RMFKGKYMGK EVAIKIL-VG KIK--NFKKL HQILYNLYNL RHSNLVLIMG VSIHYP---F VFIIYEYMKN 
---KYKKMKS RMFKGKYMGK EVAIKIL-VG KIK--NFKKL HKILYNLYNL RHSNFVLIMG VSIHYP---F VFIIYEYMKN 
---NDKIMNS RTFRGKYLGK DVAIKVL-VG RVK--DFSEI HKVFYKLHLL RHGNIALMMG VSIRYP---F VFIISEFLKN 
---NYRKLKS RVFKGKYMGK DVAIKVL-VG KIK--NFYHF HKMIYKLYVL RHSNIALIMG VAIYYP---F VFIVYEYLKN 
---RYKRLHS RVFLGKYMGK DVAIKVL-VG KIT--KFHKL YRILYKLYTL RHSNIVLIMG VSIKYP---F LFIVYEHVKN 
---KYTKLKS RVFKGKYMGK EVAIKVL-VG KIK--NFNKL HKILYKLYIL RHSNIVLIMG VSISYP---F VFIVYEYLKN 
---KPQKMKS RVFRGRYMGK DVAIKVL-VG NIK--NFTKF HKVLYKLYIL RHTNIALIMG VSISYP---F VFIIYEYIKN 
---KPQKMKS RIFRGRYMGK DVAIKVL-VG NIK--NFTKF HKVLYNLYIL RHTNIALIMG VSISYP---F VFIIYEYIKN 
---KPQKMKS RVFRGRYMGK DVAIKVL-VG NIK--NFTKF HKVLYKLYIL RHTNIALIMG VSISYP---F VFIIYEYVKN 
---NGIVMRS RTFRGKYLGK DVAIKVL-VG RVK--DFSQI HKIFYKLHLL RHGNIALMMG VSIRYP---F VFIIYEFLKN 
Figure 1. In silico annotation of PF3D7_1106800 (PfpTKL) catalytic domains. (a) PfpTKL has a pseudo-kinase 
domain. Sequence alignment between human PKAc (used as the kinase domain reference), RAF1 (used as 
a TKL reference), RIPK1 (used as a pseudo-TKL reference), BTK (used as a tyrosine kinase reference) and 
PfpTKL kinase domains. The kinase subdomains (I to XI on the sequence alignment) were delineated according 
to Hanks & Hunter23 and are shaded. Non canonical S/T kinase subdomain amino acids are shown in red and 
marked with a red star. The activation loop residues are shown in dark blue. (b) PfpTKL possesses a Bruton’s 
tyrosine kinase (BTK) N-terminal lobe-like domain upstream of its pseudo-kinase domain. Protein sequence 
alignment of BTK-like domains of PfpTKL and its Plasmodium homologs with the N-terminal lobe sequences 
of human BTK and PKAc. The alignment was created with MAFFT89 and conserved residues were shaded using 
BioEdit v7.2.5116. The ATP-binding lysine conserved across all the aligned sequences is indicated with a red 
arrow.
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was determined using glutathione S-transferase (GST) pull-down assays. A portion of PfpTKL containing RVxF1 
(residues 371–531) was produced as the recombinant protein His6-pTKL_RVxF1 (Supplementary Fig. S6) to 
test the first motif, and pTKL_KD_WT (containing RVxF2, as described above) was used to test the second one. 
PfeIf2γ-GST and GST were used as negative controls47. Both His6-pTKL_RVxF1 and pTKL_KD_WT were only 
pulled down by PfPP1c-GST beads (Fig. 5a, right panel, lanes 1 and 4).
To investigate the PfpTKL–PP1c interaction in more detail, we used Xenopus laevis oocytes as a model system 
given that X. laevis and P. falciparum PP1c share 85% identity at the amino acid level. X. laevis oocytes arrested at 
G2/M meiotic prophase I can be used to study signaling pathways involved in cell cycle progression because the 
induction of meiosis with progesterone triggers germinal vesicle breakdown (GVBD). GVBD is easily detected 
by the rise of the nucleus to the oocyte surface (visible as a white maturation spot in the animal hemisphere), 
XeCDC2 dephosphorylation (necessary for the activation of downstream pathways) and histone H3 (XeH3) 
phosphorylation, an indicator of chromosome condensation48. Previously, we showed how X. laevis oocytes could 
be used to investigate the function of P. falciparum PP1c regulators: XePP1c contributes to inhibit GVBD, so the 
micro-injection of oocytes with a PP1c inhibitor triggers GVBD whereas the introduction of an activator prevents 
progesterone-induced GVBD49.
Accordingly, we injected X. laevis oocytes with recombinant His6-pTKL_RVxF1 and pTKL_KD_WT followed 
by co-immunoprecipitation assays to determine their XePP1c-binding activity. Only pTKL_KD_WT was able to 
bind XePP1c (Fig. 5b). Interestingly, pTKL_KD_WT did not trigger GVBD in untreated arrested oocytes, show-
ing that it may not be a direct XePP1c inhibitor (Supplementary Fig. S9a), but it was able to block GVBD in the 
RVxF-1 RVxF-2
PF3D7_1106800 protein AA numbering 477      482       487      492....|....|....|....|
1213     1218    1223    1228
....|....|....|....|.
P. falciparum PF3D7_1106800 SEIKKIMNKKKVSFEYDNNE YLKNEKIKRKRKVLFSYLKTH
P. reichenowi PRCDC_1105300 SEIKKIVNKKKVSFEHDNNE YLKNEKTKMKRKVLFSYLKTH
P. knowlesi PKNH_0904400 EE-VPVLTKKILYNGDAVYQ YVKKKKKKKKKYILFTYPQPK
P. malariae PmUG01_09016400 MEKNIINDKKKTSTSKPINS YLK-RKKKKKKKVLFSYLKTQ
P. ovale PocGH01_09013500 REDKQKGQKKVSPFIKGTPD YVKRKKAKQTKKVLFSYLKRK
P. gallinaceum PGAL8A_00334100 MENKHINSKDAL-FLDGINS YLKNERKKKKKKFLFSYLKTQ
P. berghei PBANKA_0940100 NNQKIIMN-QIKSMIDQKN- YL--EKKKKKKKILFSYLKTH
P. yoelii PYYM_0941700 NKKKIMSN-QTKSMIDQKN- YL--EKKKKKKKILFSYLKTH
P. chabaudi PCHAS_0904200 DDQKIIMNKQIKSMINQKN- YF--EKKKQKNKILFSYLKTH
P. vivax PVX_091015 EE-AAVLTEKMLRSGGALYQ YVKKQKKKKKKKILFSYPQTQ
Wakula consensus sequence: [RK]-X0–1-[VI]-{P}[FW]
Meiselbach consensus sequence: [HKR][ACHKMNQRSTV]V[CHKNQRST][FW]
a
b
d
c
PF3D7_1106800 protein AA numbering      292       302       312       322       332       342       352       362                  
                                ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|... 
SAM_PF3D7_1106800               N--LIIENYQTWSLREVIQW----LMLCNVPVKWLISFYKNNITGDKLKY-ININTIRNELGIIAYGHAIKILQLIKNLQVMAY---N  
SAM_PF3D7_0926000(PfputativeK)  ------ENIYQWERHHILIL----LYLFKLN-RYIESFSSNKIKGIHFFFILNSKVLK-ELGINNKEHIFFLMNIINTFNSI------  
SAM_PF3D7_0211700(PfTKL1)       -------NYIYWNIFELNLF----FFLVGIPKEILEIFIYHRLDGYCLKY-IDKKILK-EMKIKNRMMRKYI----------------  
SAM_PF3D7_1349300(PfTKL3)       ---LRASDYNKWSVNMLYNF----LKMIGLK-KEAYLFKINKIRGYHILK-LTDKELK-KLNIN------------------------  
SAM_SDRG_01147_Sdiclina         -----------WTARQVAEW----VTRSGFA-EYAQTFEKNDITGDVLPT-ITNDVLREDLKVSAYGHRIKLVNAIQKLIEA------  
SAM_DPYK1_Ddiscoideum           -----------WAPNDVAIW----LESFNYG-QYRKNFRDNNISGRHLEG-ITHAMLKNDLGIEPYGHREDIINRLNRMIQI------  
SAM_Byr2_Spombe                 -----------YTSKEVAEW----LKSIGLE-KYIEQFSQNNIEGRHLNH-LTLPLLK-DLGIENTAKGKQFLKQRDYLREF------  
SAM_Neurabin1_human             -----------WSVQQVSHW----LMSLNLE-QYVSEFSAQNITGEQLLQ-LDGNKLK-ALGMTASQDRAVVKKKLKEMKMS------  
SAM_BOI2_Scerevisiae            -----------WSPEEITAY----FIMEGYDVQSASRFQKHKISGKILLE-LELVHLK-ELDINSFGTRFEIFKEIEKIKEA------  
SAM_BOI1_Scerevisiae            -----------WSPEEVTDY----FSLVGFDQSTCNKFKEHQVSGKILLE-LELEHLK-ELEINSFGIRFQIFKEIRNIKSA------  
SAM_Ste11_Scerevisiae           ----------------VQLF----LEEIGCT-QYLDSFIQCNLVTEEEIKYLDKDILI-ALGVNKIGDRLKILRKSKSFQRD------  
SAM_STE50_Scerevisiae           TILMNNEDFSQWSVDDVITWCISTLEVEETD-PLCQRLRENDIVGDLLPE-LCLQDCQ-DLCDGDLNKAIKFKILINKMRDSKLEWKD  
SAM_VTS1_Scerevisiae            --------TDPKLLKNIPMW----LKSLRLH-KYSDALSGTPWI--ELIY-LDDETLE-KKGVLALGARRKLLKAFGIVIDY------  
H1 H2 H3 H4 H5
5                          15                        25                    35                         45                       55                    65                      75                         85 
PF3D7_1106800 AA posion ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....| 
P. falciparum PF3D7_1106800 MGNTLDSNKP KNFVTYADYK YIGKLNNKNE HHGIGIILYN SGESFYGSFI NGKKEGKGIY IDKNLTRYIN TWVDNKVFGK VKVVP 
P. reichenowi PRCDC_1105300 MGNTLDSNKP ENFVTYADYK YIGKLNNKNQ HHGIGIILYN SGESFYGSFI NGKKEGKGIY IDKNLTRYIN TWVDNNVFGK VKVVP 
P. knowlesi PKNH_0904400 MGNSSNS-KP IKGRDFSTYR YIGELNSESV PDGKGIILHN SGEAFYGYFS NGKKNGIGIY IDKKLTKYIS NWVNDKVDGE LKVKP 
P. malariae PmUG01_09016400 MGNTTSS-KT SKYVEFENYR YIGELNNDRM PNGKGVVLYN SGESFYGSFL NGKRNGKGVY IDRMLTKYIC NWKNDKVFRG VHIIP 
P. ovale PocGH01_0901350 MGNSVDS-KP GGSVHFEKQK YVGELNNENL PHGKGTVFHY TGESFYGSFY NGKRNGRGIF IDRYLTKYIC NWKDNKVFDK VTVKP 
P. gallinaceum PGAL8A_00334100 MGNNVSS-KI NNFVEFENYK YIGELDKNNL PHGKGLILYN SGESFYGYFM NGKRNGKGIY IDKKLTKYKC NWKDDKVFKK LKINP 
P. berghei PBANKA_0940100 MGNINSI-QT KNYIKFEKYY YAGDLNVDNL PHGRGLMLYE NGNSFFGHFI NGKKHGKGIY IDKNLTKYIS KWKYDHISNK VKVKQ 
P. yoelii  PYYM_0941700 MGNGNSV-QA KKYIKFEKYY YVGDLNVDNL PHGRGLILYE NGDSFFGHFI NGKKHGKGIY INKNLTKYIS KWKYDNISNK VKVKQ 
P. chabaudi PCHAS_0904200 MGNTNST-ET NNYIKFDKYY YIGDLNVDNL PHGRGLILYE NGNSFYGNFI KGKKHGQGIY IDKNLTKYIS NWAYGNILNK VKVKR 
P. vivax PVX_091015 MGNSPDS-KP IRGRDFRGYR YIGELNDERE PNGKGLILHN SGEAFYGSFS NGKKNGIGIY INNKLTKYIC NWVNDTVDGE LKVKP
MORN Putave MORN 
(includes 1 putave N-myristoylaon site)
Figure 2. In silico annotation of PfpTKL interaction motifs and domains. (a) Plasmodium PfpTKL homologs 
share common N-terminal features beside the MORN motif(s). The alignment was created with MAFFT89 
and residues 100% conserved over all of the sequences were shaded using BioEdit v7.2.5116. The putative 
N-myristoylation site is shown in red. (b) Plasmodium PfpTKL homologs possess one or two RVxF motifs. 
The alignment was created with MAFFT89. RVxF motif consensus sequences used in silico to detect RVxF1 
and RVxF2 are displayed below the alignment86,87. (c) The PfpTKL SAM undergoes classic folding. Tertiary 
structure PfpTKL SAM predicted with Phyre281 (75 residues (97%) modeled at >90% accuracy). Structure 
annotation and shading were achieved with Chimera v1.10.1117. (d) Plasmodium SAMs showing classic 
composition compared with SAM references. Sequence alignment created with MAFFT89 between the four P. 
falciparum SAMs and reference SAMs (Sdiclina = Saprolegnia diclina, Scerevisiae = Saccharomyces cerevisiae, 
Spombe = Schizosaccharomyces pombe, Ddiscoideum = Dictyostelium discoideum). Conserved residues 
were shaded using BioEdit v7.2.5116. Arrows indicate residues conserved in SAMs. Below the alignment are 
delineated the five α-helices (H1-H5) of the SAM core118.
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presence of progesterone in 60–70% of the oocytes. The micro-injection of His6-pTKL_RVxF1 had no effect, sim-
ilar to the protein elution buffer used as a negative control (Fig. 5c). This led us to the conclusion that pTKL_KD_
WT is probably a PP1c activator, which was supported by the relatively high phosphorylation of XeCDC2 and 
the absence of phosphorylation of XeH3 (Fig. 5d). To examine the contribution of RVxF2 in more detail, we pro-
duced the recombinant protein pTKL_KD_KRIMAS in which the RVxF2 motif 1216KRKVLF1221 was mutated to 
1216KRIMAS1221 to reduce its ability to bind PP1c50 (Supplementary Fig. S6). We found that pTKL_KD_KRIMAS 
was unable to bind XePP1c and its micro-injection did not affect progesterone-induced GVBD (Fig. 5b–d).
These experiments showed that PfpTKL was able to bind and modulate PP1c via the RVxF2 motif, whereas the 
RVxF1 motif-containing region bound PP1c in vitro but did not modulate its activity.
The PfpTKL SAM domain interacts with PfSERA5. In silico analysis of the PfpTKL SAM domain 
showed that it might be involved in protein–protein interactions (Fig. 2e). To identify potential interaction part-
ners, we screened a P. falciparum cDNA library using a yeast two-hybrid (Y2H) assay with the 838–1594 bp 
portion of PfpTKL cDNA as the bait, corresponding to the SAM and RVxF1. We found that 32 clones of the 6000 
screened were able to grow on stringent media, indicating strong interactions with the PfpTKL SAM + RVxF1 
region. These represented 12 P. falciparum proteins (Supplementary Table S5). Interestingly, PfSERA5 
(PF3D7_0207600) was detected in 64% of the in-frame screening hits (Fig. 6a). PfSERA5 is the most abundant 
pseudo-protease in the parasitophorous vacuole51. To confirm this interaction, a Y2Hgold strain transformed 
with pGADT7 (either empty or encoding the longest PfSERA5 fragment identified during the Y2H screen) was 
mated to a Y187 strain transformed with pGBKT7 (empty or encoding the interaction negative control laminin, 
SAM + RVXF1 or SAM alone). The only diploids that could grow on stringent media were those expressing both 
PfSERA5 and at least the PfpTKL SAM domain, thus excluding RVxF1 as a requirement for PfSERA5 binding 
(Fig. 6b). These data confirm the strong and specific interaction between PfSERA5 and the SAM domain of 
PfpTKL.
Domain/motif 
name PfpTKL region (AA) Data from the literature PfpTKL annotation data (this study)
Kinase domain 
(KD)
1080–1483
(Fig. 1a see Supplementary 
Table S2 for details)
Kinase domains are composed of 12 subdomains23, six 
of which are critical for kinase activity25.
PfpTKL lacks some canonical KD subdomains41.
PbpTKL is a pseudokinase19.
PfpTKL KD (Fig. 1a):
—belongs to the tyrosine kinase-like (TKL) family42 (Supplementary 
Fig. S1).
—lacks the following subdomains:
-I (glycine triad)
-II (ATP-binding lysine) although there might be an alignment offset 
because the PfpTKL KD N-terminal lobe is longer than in reference 
kinases
-III (αC helix glutamate can interact with subdomain II lysine)
—includes some specificities:
-VIB aspartate (ATP γ-phosphate transfer catalyzer) is mutated to 
asparagine
-a ~50-residue insertion in its activation loop (shown in red in Fig. 1a).
Bruton’s tyrosine 
kinase-like (BTK-
like) domain
830–905
(Fig. 1b)
BTK is named after Dr Ogden Carr Bruton, who 
discovered X-linked agammaglobulinemia (XLA) in 
boys in 1952. This cytoplasmic tyrosine kinase (mostly 
in B lymphocytes) needs to bind lipids via its PH-TH 
module to adopt an active conformation104. BTK is a 
promising target in tumors105.
BTK-like domain:
—was predicted by most of the prediction tools we used.
—alignment with HsPKA and HsBTK N-terminal lobe sequences 
shows the conservation of canonical KD subdomains II (this lysine is 
shaded in red in Fig. 1b), IV (highlighted in gray) and V.
—tertiary structure prediction superimposes well with HsBTK 
N-terminal lobe (Supplementary Fig. S3).
Membrane 
occupation 
recognition nexus 
(MORN) domain
MORN1:
19–40
MORN2:
43–63
(Fig. 2a)
First identified in Junctophilins106, MORN motifs have 
been shown to bind:
-lipids and regulate kinase activity in plant PIPKs107,108
-the cytoskeleton as in TgMORN1109
-membranes and is required for the localization 
of retinophilin in the Drosophila melanogaster 
rhabdomere110
There is no signal peptide at the N-terminus of PfpTKL.
MORN1 follows the MORN motif signature: a 14–16 residue core 
domain starting with Y/FxG and ending with GxG (Supplementary 
Fig. S4).
MORN2 does not follow a canonical MORN signature but contains a 
putative N-myristoylation site that is conserved across all Plasmodium 
species (Fig. 2a).
RVxF motifs
RVxF1:
482–486
RVxF2:
1219–1223
(Fig. 2b)
RVxF motifs:
- so-called because of their binding signature111
- are the most frequent binding motifs used by PP1 
partners to interact with PP1c112
- can be predicted with consensus sequences (Fig. 2b)
RVxF1 follows the Meiselbach consensus sequence87. It is located 
in a low-complexity region, which may increase its interaction 
potential with PP1c50. It is conserved among PfpTKL homologs in P. 
praefalciparum, P. reichenowi, P. billcollinsi and P. blacklocki (Fig. 3c).
RVXF2 follows the Wakula consensus sequence86. It is located in a 
basic charged region, which could reinforce its binding potential75. It 
is conserved across all PfpTKL homologs in the genus Plasmodium 
(Figs 2b and 3c).
Sterile alpha motif 
(SAM)
299–364
(Fig. 2d)
SAMs belong to the alpha protein family (289 folds 
– SCOP database113). They typically fold into 4–5 
orthogonal α helices. They are involved in interactions 
with protein or RNA71,72.
In the Plasmodium proteome:
- there are four SAMs (PfpTKL, PfTKL1, PfTKL3, 
PF3D7_0926000)66
- there are two SAM-like domains involved in 
interactions with RNA (prototypical HTH motifs) in 
Pfg27114,115.
The PfpTKL SAM domain is predicted to fold classically (Fig. 2c).
The PfpTKL SAM core domain includes all SAM canonical residues 
(Fig. 2d).
The PfpTKL SAM domain is close to SAMs involved in protein–
protein interactions (Supplementary Fig. S5). This phylogenetic 
analysis includes Plasmodium SAM and SAM-like sequences as well as 
reference SAM and SAM-like sequences across the tree of life.
Table 1. PfpTKL domain/motif annotation results.
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Figure 3. Molecular structure and phylogenetic analysis of PfpTKL and its homologs in the Plasmodium genus. 
(a) PfpTKL molecular structure. All protein domains/motifs (MORN, SAM, RVxF, BTK-like, kinase) identified 
in silico are shown, as well as amino acid repeat regions (Asn = asparagine, Lys = lysine and Ser = serine, 
delineated using ScanProsite80). (b) Comparison of PfpTKL and its homologs. Sequence alignment was 
created in MAFFT89 and was used to assess conserved domains. Symbols on the left are linked to the proteins 
included in the phylogenetic analysis displayed in (c). (c) Phylogenetic analysis of PfpTKL and its homologs. 
Maximum likelihood phylogenetic analysis of PfpTKL homologs from: Alveolata: PF3D7 = Plasmodium 
falciparum 3D7, PFIT = P. falciparum IT, PPRFG01 = P. praefalciparum G01, PRCDC = P. reichenowi CDC, 
PRG01 = P. reichenowi G01, PBILCG01 = P. billcollinsi G01, PBLACG01 = P. blacklocki G01, PADL01 = P. 
adleri G01, PGAB01 = P. gaboni G01, PGSY75 = P. gaboni SY75, PYYM = P. yoelii yoelii YM, PY = P. yoelii 
17XNL, PBANKA = P. berghei ANKA, PCHAS = P. chabaudi, YYE = P. vinckei vinckei VINCKEI, YYG = P. 
vinckei petteri CR, PGAL8A = P. gallinaceum 8A, PRELSG = P. relictum SGS1-like, PocGH01 = P. ovale curtisi 
GH01, PmUG01 = P. malariae UG01, PKNOH = P. knowlesi Malayan PK1, PKNH = P. knowlesi H, C922 = P. 
inui San Antonio 1, PcyM = P. cynomolgi M, PVP01 = P. vivax 01, PVX = P. vivax Sal 01, GNI = Gregarina 
niphandrodes, ETH = Eimeria tenella, ENH = Eimeria necatrix, EMWEY = Eimeria maxima, BESB = Besnoitia 
besnoiti, BN1204 = Neospora caninum, HHA = Hammondia hammondi, TGDOM2 = Toxoplasma gondii 
DOM2, TGGT1 = T. gondii GT1, BN1205 = T. gondii VEG; Stramenopile: THRCLA = Thraustotheca clavata. 
Eight RAF1 protein sequences from Opisthokonta: Mammals (Rn = Rattus norvegicus, Mm = Mus musculus, 
Pa = Pongo abelii, Hs = Homo sapiens, Bt = Bos taurus), Aves (Gg = Gallus gallus), Amphibia (Xl = Xenopus 
laevis), Chromaderea (Ce = Caenorhabditis elegans) were included in the analysis as an outgroup.
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The GST pull-down assay described above was repeated using PfSERA5-His6 as the bait for PfpTKL_
SAM-GST and PfpTKL_RVxF1-GST beads, with unrelated GST-tagged proteins as negative controls 
(Supplementary Fig. S6). PfSERA5-His6 alone remained bound to PfpTKL_SAM-GST beads, confirming the 
binding specificity between the pseudo-protease and the PfpTKL SAM domain (Fig. 6c, right panel, lane 1).
PbpTKL is exported in infected host erythrocytes. Following unsuccessful attempts to knock-in 
pTKL in P. falciparum, we generated a P. berghei line expressing an auxin-induced degradation–hemagglutinin 
Kinases
ATP consumpon (A.U.)
Stascal analysis
- MBP + MBP
JNK1 348 ± 155 887 ± 367 p < 0.001
JNK1 - 22 ± 26 -
WT 346 ± 147 412 ± 142 p > 0.5
WT - 72 ± 27 -
ND 528 ± 243 588 ± 231 p > 0.5
ND - 58 ± 76 -
DG 440 ± 122 405 ± 209 p > 0.5
DG - 49 ± 36 -
a
b
c
WT + + + - - - - - -
ND - - - + + + - - -
DG - - - - - - + + +
ATP-agarose beads - + - - + - - + -
Agarose beads - - + - - + - - +
kDa
250 –
100 –
70 –
55 –
35 –
10 –
PfpTKL_KD
Pf
pT
KL
_K
D
Figure 4. PfpTKL kinase domain (pTKL_KD_WT) and its mutants (pTKL_KD_ND and pTKL_KD_DG) 
bind ATP but do not display any kinase activity in vitro. (a) Plasmodium pTKL kinase domain binds ATP. 
Wild-type and mutated recombinant pTKL kinase domains were incubated with ATP-agarose or agarose beads. 
Eluates were separated by SDS-PAGE and His6-tagged proteins bound to the beads were detected by western 
blot. (b) Plasmodium pTKL kinase domain does not catalyze kinase reactions. Kinase reactions performed 
with γ33P-ATP were stopped by the addition of loading buffer and separated by SDS-PAGE. Gels are displayed 
according to the substrate: myelin basic protein (left panel), P. falciparum and erythrocyte extracts (right panel). 
WT = wild-type recombinant kinase domain, ND = N1272D mutant and DG = 1290DFG1292 to 1290GFE1292 mutant. 
IP = immunoprecipitated PbpTKL-AID-HA. JNK1 was used as an active kinase control. (c) Plasmodium pTKL 
kinase domain binds ATP but does not display any kinase activity. WT and mutant recombinant pTKL kinase 
domains were distributed in plates in the presence or absence of myelin basic protein used here as a substrate. 
JNK1 was used as an active kinase control and all kinases were also heated (∆) to generate negative controls. 
After incubation at 37 °C for 2 h, the quantity of free ATP remaining in wells was evaluated by luminometry. The 
ATP consumption displayed in the table corresponds to the difference between the luminometry value obtained 
without kinase and the luminometry value obtained with the maximum amount of kinase (80 ng/well for JNK1, 
and 8 µg/well for PfpTKL) (mean ± SD; three biological replicates and three technical replicates per data point – 
raw data are available in Supplementary Table S4).
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Figure 5. Both PfpTKL RVxF1 and RVxF2 motifs bind PfPP1c in vitro but only RVxF2 exerts a functional role 
in Xenopus laevis oocytes. (a) RVxF1 and RVxF2 both directly bind PfPP1c in vitro. PfPP1c-GST, PfeIf2γ-GST 
or GST (the last two = negative control) beads were incubated with His6-pTKL_RVxF1 (RVxF1) or pTKL_KD_
WT (KD_RVxF2). Following washes, beads were eluted in Laemmli buffer. Proteins were separated by SDS-
PAGE and His6-tagged proteins bound to beads were identified by western blot (WB, right panel – both blot 
first lanes show the specific and direct interaction of RVxF1 and KD_RVxF2 with PfPP1c-GST). All inputs were 
analyzed by western blot as well (left panel). Uncropped blots are available in the Supplementary Information. 
(b) Only RVxF2 binds XePP1c in vivo. RVxF1, KD_RVxF2 and KD_KRIMAS (containing RVxF2 inactivated 
by mutation) were micro-injected into X. laevis oocytes. To check for the presence of RVxF-containing proteins, 
oocytes were lysed and His6-tagged proteins were separated by SDS-PAGE and detected by western blot (left 
panel). Oocytes micro-injected with RVxF1, KD_RVxF2 or KD_KRIMAS and incubated with progesterone 
were lysed 15 h after micro-injection and anti-XePP1c immunoprecipitation assays (IP) were performed. After 
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(AID-HA)-tagged PbpTKL to study the subcellular localization of pTKL throughout the asexual life stages 
(Supplementary Fig. S7a). PfpTKL and PbpTKL share a global 36% identity and a protein domain conservation 
of 50–70% (Supporting Information). The only difference between the two orthologs is the absence of RVxF1 
in P. berghei, but as described above this sequence does not appear to be required for PP1c modulation (Fig. 5). 
Immunofluorescence assays using synchronized intra-erythrocytic stages of the PbpTKL-AID-HA line revealed 
that PbpTKL was exported within the infected erythrocytes and was not detected in the parasite from the early 
to late trophozoite stages (Fig. 7a). Small amounts of PbpTKL were secreted during the early trophozoite stages, 
but from the late trophozoite to schizont stages the protein filled the entire erythrocyte cytosol, and probably also 
the parasitophorous vacuole (Fig. 7a). The active export of PbpTKL within the infected erythrocytes was further 
confirmed by treating PbpTKL-AID-HA trophozoites with brefeldin A (BFA), described as an inhibitor of pro-
tein transport52. In BFA-treated trophozoites, PbpTKL was solely detected within the parasite cytosol as expected 
(Fig. 7b,d). Given that pTKL lacks a PEXEL motif and a predicted signal peptide, this also indicates that PbpTKL 
is a PEXEL-negative protein (Table 1).
To confirm these observations, the sequential lysis of infected erythrocytes was performed on trophozoites 
and schizonts, followed by anti-HA immunoprecipitation (Supplementary Fig. S8). During the trophozoite 
stages, PbpTKL-AID-HA was detected in the parasitophorous vacuole fraction and was also associated with 
erythrocyte ghosts. However, it was not detected in the infected erythrocyte cytosolic fraction, suggesting that 
the protein may be associated only with the erythrocyte membrane and cytoskeleton. During the schizont stages, 
PbpTKL-AID-HA was detected in both the parasite and the parasitophorous vacuole fractions, but was no longer 
associated with erythrocyte ghosts (Fig. 7c).
PbpTKL interactome in trophozoite-infected erythrocytes. To determine whether the exported 
PbpTKL interacts with erythrocyte proteins, we screened for interaction partners in trophozoite-infected mouse 
erythrocytes using anti-HA immunoprecipitation. We screened the total lysates of erythrocytes infected with a 
wild-type parental P. berghei line and ghost lysates of erythrocytes infected with the P. berghei line expressing 
PbpTKL-AID-HA. Proteins that remained bound to the anti-HA beads were analyzed by mass spectrometry, 
and those absent in the wild-type samples but present in at least two ghost samples from three experiments were 
selected. The resulting list of 23 mouse proteins (Fig. 7e; Supplementary Table S6) was assessed for cellular func-
tions using the Uniprot database53, GO annotation and interactome data available in the STRING database54. Six 
of the proteins were found to be involved in the organization or dynamic modulation of the actin cytoskeleton, in 
agreement with the localization data presented above (Fig. 7a,c). Three further proteins were found to be involved 
in the intracellular trafficking of ions and vesicles. Another seven proteins were members of the proteasome com-
plex or involved in the regulation of protein ubiquitination, such as ISG1555. The list also included two ribosomal 
proteins involved in translation and two proteins involved in the physiological response to oxidative stress. The 
last three proteins were not considered relevant due to the subcellular localization data available on Uniprot53 
(Supplementary Table S6). Attempts to find PbpTKL interaction partners in schizonts did not lead to any exploit-
able data given the low expression level of PbpTKL during these stages (PbpTKL-AID-HA was detected in only 
one of three replicates).
PbpTKL is not required to complete the intra-erythrocytic cycle or gametocyte emer-
gence. PbpTKL was recently found to be dispensable for the completion of intra-erythrocytic development56. 
This result was thus in conflict with the systematic functional analysis of the P. berghei kinome19. Both stud-
ies were based on similar approaches (i.e., gene disruption by double homologous recombination), but differed 
mainly in the length of the cloned homology regions, which favor recombination during PlasmoGEM screening56. 
We therefore attempted to generate a pTKL-knockout P. berghei line (pGEM) by introducing the readily available 
PlasmoGEM pTKL construct (PbGEM-342364) into the PbGFP ANKA strain (Supplementary Fig. S7b). After 
selection, pyrimethamine-resistant parasites were cloned and analyzed by genomic PCR to confirm the correct 
recombination events (Supplementary Fig. S7b). However, both the 5′ end of the PbpTKL transcript (amplified 
using primers F5′/GW2, including the MORN domains) and its 3′ end (amplified using primers F28/R29, poten-
tially including at least the KD) were detected by RT-PCR (Supplementary Fig. S7b). Furthermore, primers GW1/
GT did not detect the dhfr resistance cassette, thus excluding the expression of a chimeric transcript compris-
ing the PbpTKL 5′ region, resistance cassette and PbpTKL 3′ region. Phenotypic analysis of PbpTKL knockout 
parasites showed identical parasitemia and survival rates compared to the wild-type parental strain (Fig. 8a,b). 
Furthermore, there was no difference between the lines in terms of gametocyte production, male/female gameto-
cyte ratio and male gametocyte activation (exflagellation) (Fig. 8c–e). Because we could not exclude the possibility 
that the lack of phenotype reflected the partial expression of PbpTKL, we used the AID-HA knock-in approach57 
in a TIR1-expressing P. berghei ANKA pG230 strain. Clones were confirmed by diagnostic PCR (Supplementary 
washes, proteins bound to beads were detected by western blot (right panel). (c,d) RVxF2 inhibits progesterone-
induced germinal vesicle breakdown (GVBD) in X. laevis oocytes. (c) Chart showing GVBD percentage over 
time in progesterone-incubated X. laevis oocytes micro-injected either with proteins or with control buffers 
(mean ± SD; three biological replicates and two technical replicates with 10 oocytes per data point). Oocyte 
images (external view and hemisections) are available for each sample in the Supplementary Information. 
***, p < 0.001. (d) GVBD of oocytes micro-injected with RVxF-containing proteins was assayed by analyzing 
XeCDC2 dephosphorylation and XeH3 phosphorylation by western blot. Only KD_RVxF2 (third lane) was able 
to block progesterone-induced XeH3 phosphorylation. Lower panel, western blot analysis of total XeCDC2 and 
XeH3. Uncropped blots are available in the Supplementary Information.
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Figure 6. PfpTKL SAM domain interacts specifically with PfSERA5. (a) PfSERA5 is the main binding partner 
of the PfpTKL SAM. P. falciparum proteins interacting with the PfpTKL SAM + RVxF1 region were identified 
by yeast two-hybrid (Y2H) screening. The percentage occurrence of each interacting protein is plotted for 
clones in frame with GAL4AD. All the hits returned by the screening are available in Supplementary Table S5. 
(b) PfSERA5 interacts strongly and specifically with the PfpTKL SAM in yeast. The chart shows the results 
of the mating run between Y2Hgold cells transformed with pGADT7 (either empty (Ø) or cloned with the 
longest PfSERA5 cDNA sequenced during Y2H screening) and Y187 cells transformed with pGBKT7 (empty 
(Ø), encoding laminin as a negative interaction control or SAM + RVxF-1 or SAM only). Diploids were either 
streaked on TDO/A medium (left panel) or QDO/A medium (right panel). (c) PfSERA5 interacts directly with 
the PfpTKL SAM in vitro. His6-tagged PfSERA5 (His6-SERA5) was incubated with pTKL_SAM-GST, pTKL_
RVxF1-GST, PfeIf2γ-GST, PfPP1c-GST or GST (the last three = negative controls). After washes, proteins were 
eluted in Laemmli buffer, separated by SDS-PAGE and detected by western blot (WB, right panel). Inputs were 
also detected by western blot (left and middle panels). His6-tagged PfSERA5 binds directly to pTKL_SAM-GST 
(first lane on right). Uncropped blots are available in the Supplementary Information.
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Figure 7. PbpTKL is exported in the erythrocyte during the trophozoite stages and binds host erythrocyte 
proteins. (a,b) PbpTKL is actively exported from the parasite between the trophozoite and schizont stages. 
(a) Confocal microscopy images showing the localization of the PbpTKL-AID-HA protein (red) in infected 
erythrocytes at different stages (top to bottom: merozoite, ring, early trophozoite, late trophozoite and 
schizonts). Parasite nuclei are stained with Hoechst (blue). The erythrocyte membrane is labeled after detection 
of TER119 (white). Bar = 5 µm. (b) Confocal microscopy images showing the localization of PbpTKL-AID-HA 
in brefeldin A (+BFA) treated trophozoites. PbpTKL-AID-HA (red, BFA aggregates) is no longer exported 
but retained within the parasite cytosol (GFP signal). Bar = 5 µm. (c) PbpTKL associates with ghosts during 
the trophozoite stages based on sequential lysis results (Supplementary Fig. S8). Fractions were verified by 
western blot (WB): anti-HsPP1c recognizes mouse PP1c in the erythrocyte cytosol, anti-TER119 recognizes 
mouse erythrocyte ghosts, and anti-rPyEXP2 recognizes PbEXP2 in the parasite cytosol, parasitophorous 
vacuole and vesicles in the host erythrocyte cytosol119. Anti-HA immunoprecipitation assays were performed 
on each fraction and PbpTKL-AID-HA was detected by anti-HA western blot. Uncropped blots are provided 
in the Supplementary Information. (d) PbpTKL is actively exported to the host erythrocyte cytosol. Sequential 
lysis on P. berghei trophozoites treated with BFA (verified by fraction analysis using anti-rPyEXP2, as opposed 
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Fig. S7a), and the degradation of PbpTKL-AID-HA following the incubation of parasites in vitro with auxin was 
confirmed by western blot (Fig. 8f). The intra-erythrocytic cycle was completed and male gametocyte exflagella-
tion occurred similarly in the parasite cultures in the presence or absence of auxin (Fig. 8h).
Together, these data show that PbpTKL is probably not required to complete the intra-erythrocytic cycle or to 
support gametocyte production and male gametocyte activation.
Discussion
The Plasmodium kinome is mainly composed of S/T kinases with key roles in parasite development20. Although 
the multiple roles of pseudokinases are well known in higher eukaryotic cells28–36, little is known about apicompl-
exan pseudokinases. We therefore characterized pTKL, a pseudokinase specific to certain apicomplexan parasites, 
including Plasmodium species. Our results demonstrated that in P. berghei, PbpTKL is expressed mostly during 
the trophozoite stages and the protein is exported to the host cell where it associates with ghosts, i.e. the eryth-
rocyte membrane and cytoskeleton58. During the schizont stages, PbpTKL is retained within the parasite and 
parasitophorous vacuole. Because PbpTKL is PEXEL-negative and lacks a signal peptide as well as a transmem-
brane domain, its export mechanism remains unclear. We propose that pTKL crosses the parasite plasma mem-
brane using its hydrophobic MORN motifs. Either both of them or mostly MORN2 which contains a putative 
N-myristoylation site could also allow the protein to associate with erythrocytic ghosts. This is further supported 
by the fact that MORN motifs bind to membranes and cytoskeleton (Table 1). Importantly, our interactome anal-
ysis revealed that PbpTKL interacts with actin cytoskeleton-binding proteins (Fig. 7e). PbpTKL may therefore be 
involved in the remodeling of the erythrocyte cytoskeleton or membrane, as shown for other unessential exported 
proteins such as PfFIKK7.1 and PfFIKK1259, PbSMAC60 and PbRESA61.
When exported to the host erythrocyte cytosol, PbpTKL was found to reside at the crosstalk of two main 
protein networks. The first is composed of three proteins involved in cellular trafficking, and the second regulates 
protein expression and degradation (the seven members of this network include ribosomal proteins, regulators of 
ubiquitination and proteasome components). These proteins are classically found in erythrocyte ghost samples58. 
They are involved in the last steps of erythropoiesis, during which hemoglobin synthesis increases while other 
proteins, including ribosomal proteins, are degraded. This process ensures the simplification of the proteome as 
cells mature from reticulocytes to erythrocytes, in which 98% of all protein molecules are globin62,63. Two proteins 
involved in oxidative stress regulation were also detected in the PbpTKL ghost interactome. Such proteins play a 
key role in maintaining erythrocytes by protecting them from the continuous oxidative stress they experience due 
to their oxygen transport role64. PbpTKL might thus favor the implementation of host–pathogen communication 
pathways as already described for many classical code-breaking pseudo-kinases and truncated kinases65.
From a biochemical point of view, the PfpTKL catalytic site can bind ATP in a cation-independent manner, 
confirming that it belongs to the class 2 pseudokinases26. However, the PfpTKL KD was catalytically inactive 
under our experimental conditions, probably due to the lack of canonical subdomains I-III and VI which usually 
play key roles in ATP stabilization and γ-phosphate group transfer25. Notably, the native PbpTKL-AID-HA pro-
tein also lacked catalytic activity (Fig. 4b). The role of the BTK-like domain and potentially of the SAM domain in 
terms of regulation of KD activity (as shown for Pf TKL366) remains unclear. However, in addition to interaction 
data collected from ghost samples, the ability of the pTKL KD to bind ATP could turn the protein into an enzyme 
cofactor within the erythrocyte cytosol. Furthermore, ATP is an important messenger for erythrocytes67: it is 
released during hypoxia, oxidative stress or infection by Plasmodium species and may therefore mediate commu-
nication between infected cells and uninfected bystander erythrocytes68. The parasite may export an ATP-binding 
protein and anchor this to the host cell cytoskeleton as a strategy to modulate ATP release during its replication.
In parallel, we showed that PfpTKL interacts with two parasite proteins in vitro and in heterologous models. 
The RVxF motifs of PfpTKL can bind PfPP1c, the major phosphatase of this parasite69,70. Interaction studies in the 
X. laevis oocyte model showed that only RVxF2 binds XePP1c in vitro and also influences GVBD. This suggests 
that RVxF1 may interact transiently with PP1c in vivo to bring pTKL and PP1c closer, probably only during the 
schizont stages where both pTKL and PP1c are localized in the parasite. RVxF2, which is conserved in all pTKL 
homologs across the Plasmodium genus, appears to bind PP1c more strongly than RVxF1 and also allows the 
allosteric modulation of phosphatase activity.
Using a Y2H assay, we found that the PfpTKL SAM domain binds strongly and specifically to PfSERA5, an 
abundant parasitophorous vacuole pseudo-protease that is expressed during the P. falciparum schizont stages and 
is involved in the egress of merozoites51. PfSERA5 does not appear to be conserved in P. berghei, so the PbpTKL 
SAM domain may interact with another member of the SERA family in this species. Although SAM domains 
feature simple and uniform primary, secondary and tertiary structures, they can bind to different proteins and 
nucleic acids71,72. The PbpTKL SAM domain may therefore interact with other proteins when it is exported to 
the host cell cytosol. Although we could not confirm an interaction between PbpTKL and PbPP1c or a PbSERA 
to fraction analysis without treatment shown in (c). Anti-HA IP assays were performed on each fraction and 
PbpTKL-AID-HA was detected by anti-HA western blot. Uncropped blots can be found in the Supplementary 
Information. (e) Exported PbpTKL binds erythrocyte proteins. Volcano plot showing proteins identified by 
mass spectrometry after anti-HA immunoprecipitation assays on PbpTKL-AID-HA versus wild-type pG230 
P. berghei-infected erythrocytes (y-axis shows negative log p-value, x-axis shows fold-change between wild-
type and PbpTKL-AID-HA samples). Squares = P. berghei proteins; circles = mouse proteins. Proteins absent 
from wild-type samples and detected in at least two of three PbpTKL-AID-HA ghost samples are shown on the 
upper right panel of the chart (see caption). Three biological replicates were analyzed per sample type (raw and 
interactome mouse protein analysis data are available in Supplementary Table S6).
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Figure 8. PbpTKL is dispensable for intra-erythrocytic cycle completion, gametocyte emergence and male 
gametocyte exflagellation. (a–e) Data collected using mice infected either with the wild-type PbGFP strain 
(parental) or the PbGEM-342364-transfected strain (pGEM) – 106 parasites/mouse, seven mice per group. 
(a) Knocking out PbpTKL does not impact parasitemia. Parasitemia follow-up in mice infected either with 
the parental or pGEM P. berghei parasites (mean ± SD). (b) Knocking out PbpTKL does not improve mouse 
survival. Percent survival of mice infected with either parental or pGEM P. berghei parasites. (c) Knocking 
out PbpTKL does not affect gametocyte emergence. Gametocytemia follow-up in mice infected with either 
with the parental or pGEM P. berghei parasites (mean ± SEM). (d) Knocking out PbpTKL does not affect 
male/female gametocyte ratio. Male/female ratios were evaluated in mice infected either with the parental or 
pGEM P. berghei parasites (data points and means ± SD are shown). (e) Knocking out PbpTKL does not affect 
male gametocyte exflagellation. Exflagellation center numbers were assayed for parental and pGEM parasites 
at a parasitemia of 10–20% and > 20% (data points and means ± SD are shown). (f–h) Data collected using 
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family member in schizonts due to the low PbpTKL expression level, we found a strong correlation between the 
interactions identified in vitro and the localization of the protein and its partners in the same compartments 
during the schizont stages.
Having tested the catalytic and scaffolding roles of pTKL, we next investigated whether the protein is required 
during the P. berghei blood stages. The phenotypic analysis of PbGEM-342364-transfected P. berghei and the use 
of the AID knockdown system led us to the conclusion that PbpTKL is probably not required for the completion 
of the intra-erythrocytic cycle or for gametocyte emergence, in agreement with a recent saturation mutagenesis 
study in P. falciparum73. Thirteen piggyBac transposons could be inserted within the PfpTKL locus and surround-
ing intergenic regions without affecting P. falciparum intra-erythrocytic development, suggesting the protein is 
dispensable for blood stage parasites. However, we cannot exclude the possibility that the PbpTKL MORN motifs 
or KD may continue to be expressed in the knockout line. Although we also used the in vitro AID system, which is 
useful to determine whether proteins are essential for invasion, cell cycle completion or gametocyte activation57, 
it may not be suitable for the analysis of proteins that are rapidly exported to the parasitophorous vacuole or the 
host cell after their synthesis, even though we observed that PbpTKL degradation was induced in trophozoites in 
the presence of auxin.
In conclusion, we have shown that the Plasmodium pseudo-kinase pTKL can bind ATP and acts as a protein 
scaffold at the host–pathogen interface. Although probably unnecessary during the blood stages, it remains to 
be demonstrated whether this protein is required during the mosquito and/or liver stages of parasite develop-
ment. Indeed, a recent single-cell transcriptomics study showed that PbpTKL is strongly transcribed during the 
Plasmodium liver stages (Malaria Cell Atlas74).
Materials and Methods
Materials. Commercial plasmids were sourced from Invitrogen (pCR2.1-TOPO), Novagen (pETDuet-1), GE 
Life Sciences (pGEX-6P3), Qiagen (pMALpIII), and Clontech (pGBKT7 and pGADT7), whereas pG362 and 
PbGEM-342364 were kindly provided by Dr N. Philip (The University of Edinburgh, Edinburgh, UK) and the 
Plasmogem-Wellcome Sanger Institute (Cambridge, UK), respectively. The P. falciparum cDNA bank used for 
Y2H library preparation was described in an earlier study75.
Primary antibodies were sourced from Invitrogen (anti-His6), Thermo Fisher Scientific (anti-GST), StemCell 
(TER119) and Roche (rat anti-HA and anti-GFP). Anti-HsPP1c (clone E9) and anti-XePP1c were provided by 
Santa Cruz Biotechnology. Rabbit anti-HA, anti-Cdc2, anti-phospho-Cdc2 (Tyr15) and anti-phospho-histone 
H3 (Ser10) polyclonal antibodies were provided by Cell Signaling Technology. Anti-histone H3 was provided by 
Novus Biological. Secondary highly-cross-adsorbed antibodies were obtained from Invitrogen. Anti-rPyEXP2 
was a kind gift from Dr J. Burns (Drexel University College of Medicine, Philadelphia, USA).
Equinatoxin II (EQT) was a kind gift from Dr G. Anderluh (National Institute of Chemistry, Ljubljana, 
Slovenia)76.
Transcript sequencing and sequence confirmation. Pf3D7 total RNA was extracted from 
saponin-lysed parasites using TRIzol (Thermo Fisher Scientific) and reverse transcribed into cDNA using the 
SuperScript III First-Strand Synthesis Super Mix kit (Invitrogen) following the manufacturer’s instructions. The 
cDNA was used to amplify and clone overlapping regions of the PF3D7_1106800 (PfpTKL) transcript into vector 
pCR2.1-TOPO using primers F1–R12 (Supplementary Fig. S1 and Table S1). Following the transformation of 
TOP10 bacteria and clone sequencing, 6–12 sequences per region were compiled into one consensus covering the 
whole PfpTKL transcript using SeqMan for comparison with PlasmoDB data43.
Protein annotation. The PfpTKL protein sequence was analyzed using SMART77, CATH78, Interpro79 
and ScanProsite80. The tertiary structure was determined using the prediction tools Phyre2 Server81, M4T82 and 
RAPTOR83 (all well ranked by CAMEO84,85). RVxF motifs were identified based on two consensus sequences86,87 
(Fig. 2b) and the PlasmoDB Protein Motif Pattern tool. Low-complexity regions and putative post-translational 
modifications were predicted using ScanProsite80. Signal peptides were predicted using SignalHmmS88.
Phylogenetic analysis. We identified 48 PfpTKL (PF3D7_1106800) homologs via back-and-forth 
PSI-BLAST analysis, first using the PfpTKL sequence as a query, and then using PSI-BLAST results as queries 
against the Pf3D7 proteome. Candidates were confirmed as PF3D7_1106800 homologs when pTKL was the high-
est scoring hit (except for the RAF1 outgroup). Verified sequences were then retrieved from PlasmoDB43 or 
Uniprot53 for non-Plasmodium proteins before inclusion in the phylogenetic analysis. The 128 SAM amino acid 
sequences were retrieved from Uniprot53.
cloned pG230 P. berghei parasites expressing PbpTKL-AID-HA, after incubation with or without the auxin 
3-idoleacetic acid (IAA). (f) PbpTKL-AID-HA is degraded in vitro in the presence of IAA. PbpTKL-AID-HA 
parasites were incubated either with (+IAA) or without IAA (−IAA). After total lysis of incubated parasites, 
immunoprecipitation assays (IP) were performed using anti-HA agarose beads. PbpTKL-AID-HA was 
detected by western blot (WB) using anti-HA antibodies. Uncropped blots are available in the Supplementary 
Information. (g) Inducible knockdown of PbpTKL does not prevent completion of the intra-erythrocytic cycle. 
In vitro follow-up of PbpTKL-AID-HA parasite stages after synchronized infection in mice (five per group) 
– parasites were cultured in the presence (+IAA) or absence (−IAA) of IAA, hpi = hours post-intravenous 
injection of Nycodenz-enriched schizonts (mean ± SD). (h) Inducible knockdown of PbpTKL does not affect 
male gametocyte exflagellation. Exflagellation centers were assayed for PbpTKL-AID-HA parasites after 
incubation with (+IAA) or without IAA (−IAA) (mean ± SD). ns, no significant difference.
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For each phylogenetic analysis, sequences were aligned using MAFFT89 (Supplementary Information) and 
evolutionary history was inferred using the maximum likelihood method based on the JTT matrix model in 
Molecular Evolutionary Genetics Analysis v6 (MEGA6)90,91. All positions with less than 80% site coverage were 
eliminated, leaving 598 positions in the final PfpTKL dataset and 64 in the final SAM dataset. The initial tree for 
the heuristic search was obtained by applying the neighbor-joining method to a matrix of pairwise distances 
estimated using a JTT model. For PfpTKL, a discrete gamma distribution was used to model evolutionary rate 
differences among sites. Evolutionary history was represented by the bootstrap consensus tree inferred from 1000 
replicates92. The tree was visualized using MEGA6 and edited in Inkscape v0.92.
Recombinant protein production and purification. GST, PfPP1c-GST, PfPP1c-His6 and PfeIf2γ-GST 
were produced as previously described47,93. PfpTKL_KD_WT was synthesized (Eurofins) as a re-codonized 
synthetic gene (synthetic gene 2 in Supplementary Information) and transferred to pMALPIII to stabilize the 
recombinant protein via an N-terminal fusion to the maltose binding protein94,95 with a C-terminal His6 tag. 
The resulting construct was introduced into the Escherichia coli strain JM109. The PfpTKL_KD_WT construct 
was mutated by PCR targeted mutagenesis as previously described96. The N1272D mutant (pTKL_KD_ND) was 
prepared using primers F22/R23, the 1290GFE1292 mutant (pTKL_KD_DG) was prepared using primers F24/R25, 
and the 1218KRIMAS1222 mutant (pTKL_KD_KRIMAS) was prepared using primers F26/R27 (Supplementary 
Table S1).
The pTKL_RVxF1 recombinant proteins with His6 or GST tags were prepared by cloning PfpTKL (cDNA 
1114–1594 bp) in vectors pETDuet-1 and pGEX-6P3 using primers F13/R14 (Supplementary Table S1) and intro-
ducing them into E. coli strains C41 and AD494, respectively, to produce the proteins His6-pTKL_RVxF1 and 
GST-pTKL_RVxF1. The SAM domain (cDNA 838–1149 bp) was re-codonized by GenScript (synthetic gene 1 in 
Supplementary Information), transferred to vector pGEX-6P3 and introduced into E. coli strain AD494 (recom-
binant protein pTKL_SAM). The His6-tagged SERA5 was obtained by cloning PfSERA5 (PF3D7_0207600) cDNA 
(432–1089 bp) directly from Y2H screening clone 3457 (Supplementary Table S5) into pETDuet-1 using primers 
F20/R21 (Supplementary Table S1). The resulting construct was introduced into E. coli strain BL21 (recombi-
nant protein His6-PfSERA5). All recombinant protein constructs were verified by sequencing (Supplementary 
Information).
The expression of recombinant proteins was induced at 16 °C overnight shaking at 200 rpm in the presence of 
0.5 mM IPTG (and 1 mM MgSO4 as a kosmotrope for the pTKL_KD proteins97). Cells were harvested in ice-cold 
sonication buffer (20 mM Tris pH 7.5 or 8, 300 mM NaCl, 20 mM imidazole, 0.2 U/mL DNase, Roche cOmplete 
EDTA-free anti-protease cocktail, 0.02 mg/mL lysozyme, 1% Triton X-100, and 1 mM MgSO4 for the pTKL_KD 
proteins). His6 and GST tagged proteins were purified on Ni-NTA beads (Jena Bioscience) and glutathione beads 
(Sigma-Aldrich) respectively, according to the manufacturer’s instructions (Supplementary Fig. S6).
Protein concentrations were measured using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific).
Kinase activity assay. Recombinant pTKL_KD_WT, pTKL_KD_ND and pTKL_KD_DG were purified 
on beads as described above. Beads were suspended in purification washing buffer (20 mM Tris pH 7.5, 300 mM 
NaCl, 20 mM imidazole, 1 mM MgSO4) and the concentration was determined using the Pierce BCA Protein 
Assay Kit. 400–800 µg of protein were used per test. Endogenous PbpTKL-AID-HA was immunoprecipitated on 
HA-agarose beads as described below. Beads were washed and equilibrated in assay washing buffer (20 mM Tris 
pH 7.5, 1 mM DTT, 200 µM activated sodium orthovanadate, Roche cOmplete EDTA-free anti-protease cock-
tail). JNK1 (Sigma-Aldrich) was used as a positive control (1 µg per test). We mixed 20 µL of kinase (either beads 
or free protein) with 5 µg of substrate, 10 µL of 10 μCi ATP [γ-33P] (PerkinElmer Life Sciences) and ATP, final 
concentration 50 µM, in 40 µL of wash buffer. After incubation for 1 h at 37 °C, kinase reactions were stopped by 
adding Laemmli buffer. Samples were analyzed by SDS-PAGE. The resulting gel was fixed with 10% acetic acid 
and 10% methanol before drying. The incorporation of [γ-33P] was visualized and quantified using a PharosFX 
Plus Molecular Imager.
ATP affinity assay. Recombinant kinases were dialyzed against PBS containing 1 mM DTT and 1 mM EDTA 
overnight at 4 °C and then assayed for ATP affinity using the ATP Affinity Test Kit (Jena Bioscience) according to 
the manufacturer’s protocol.
ATP hydrolysis assay. ATP hydrolysis activity was evaluated using the Kinase Glo Luminescent Kinase 
assay kit (Promega). Beads prepared as described above were distributed in increasing quantities in white 96-well 
plates in washing buffer (20 mM Tris pH 7.5, 1 mM DTT, 200 µM activated sodium orthovanadate, Roche cOm-
plete EDTA-free anti-protease cocktail) to 20 µL per well. ATP buffer (washing buffer containing 3.3 µM ATP, 
16.7 µg/mL MBP and 3.3 mM MgCl2) was then added to a final volume of 50 µL per well. JNK1 was used as a 
kinase positive control. After incubation at 37 °C for 2 h shaking at 54 rpm in the dark, Glo reagent equilibrated 
to room temperature was added (50 µL per well) and the plate was incubated shaking at 100 rpm for 10 min in 
the dark at room temperature before measuring the luminescence on a TECAN Spark 10 M luminometer (see 
Supplementary Table S4 for raw data).
GST pull-down assay (RVxF interaction with PfPP1c-GST). GST pull-down assays were pre-
pared as previously described47. Briefly, 2 μg of recombinant His6-pTKL_RVxF1, pTKL_KD_WT or pTKL_
KD_KRIMAS was incubated with PfPP1c-GST, PfeIF2γ-GST (negative interaction control) or GST bound to 
glutathione-Sepharose beads, and 25 µg of bovine serum albumin (BSA) in binding buffer (20 mM Tris-HCl pH 
7.4, 500 mM NaCl, 20 mM HEPES, 0.2 mM EDTA, 0.1% Triton X-100, 1 mM DTT, Roche cOmplete EDTA-free 
anti-protease cocktail, 1 mM MnCl2, 50 µM ZnCl2) for 2 h at 4 °C on a rotating wheel. After three washes, proteins 
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were analyzed by western blot using an anti-His6 antibody (diluted 1:1000) or an anti-GST antibody (diluted 
1:2000).
Ethics statement for animal experimentation. Experiments were carried out in accordance with the 
principles of the European Community Council recommendations (86/609/EEC) for animal experimentations. 
All animal procedures were approved and supervised by the local Ethics Animal Committee (CEEA-75 Comité 
d’Ethique en Expérimentation Animale, Nord - Pas de Calais, France). The ethical approval number for protocols 
and procedures on mice (male CD1 (22–24 g) from Charles River Laboratories) is 00527.04. Experiments con-
ducted on X. laevis (University of Rennes, UMS 3387) were approved likewise (CEEA 07/2010).
X. laevis oocyte assays. Oocytes were micro-injected 1 h before incubation in 10 µM progesterone as pre-
viously described96 (although with recombinant proteins rather than synthetic mRNA). GVBD was assessed by 
checking for the appearance of a white spot at the surface of activated oocytes and by verifying the absence of any 
nucleus inside activated oocytes (hemisections of oocytes were prepared). XePP1c was immunoprecipitated 2 or 
15 h after micro-injection98.
Yeast two-hybrid assay. A PfpTKL cDNA segment including the SAM domain and RVxF-1 motif (residues 
255–371) was transferred to vector pGBKT7 using primers F15/R16 (Supplementary Table S1) and introduced 
into Y187 competent yeast cells (Clontech) according to the manufacturer’s instructions. The resulting strain was 
used as a bait to screen protein interactions by mating with Y2Hgold cells transformed with the P. falciparum 
cDNA library in vector pGADT775. Mating produces diploids that are viable on double dropout/aureobasidine 
(DDO/A) medium. We streaked 6000 diploids that grew on DDO/A post-mating on triple dropout/A (TDO/A) 
plates and then on quadruple dropout/A (QDO/A) plates, as increasing stringency allowed for interaction eval-
uation75. Only 32 diploids were able to develop on QDO/A medium (Supplementary Table S5). Plasmid DNA 
recovered from 31 of the 32 diploids was introduced into E. coli strain DH5α and checked for the presence of 
an insert by digestion with SfiI. Finally, the insert sequences were used as BLAST queries against PlasmoDB43 to 
identify putative PfpTKL SAM interactors. For further Y2H assays, a Y2Hgold strain expressing the SAM alone 
was generated by mutating construct SAM + RVxF1_pGBKT7 using primers F17/R18.
GST pull-down assay (SAM-GST interaction with PfSERA5–6His). The pTKL_SAM-GST, 
PfPP1-GST, PfeIF2γ-GST, pTKL_RVxF1-GST or GST proteins bound to glutathione-Sepharose beads were 
blocked with 25 μg BSA in binding buffer (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 1 mM MnCl2, 50 μM ZnCl2) 
for 1 h at 4 °C on a rotating wheel. We incubated 1 μg of recombinant PfSERA5-His6 protein with blocked beads 
for 30 min, and bound proteins were detected as described above.
Purification of stage-specific P. berghei parasites. Parasite stages were isolated as previously 
described99. Briefly, for schizonts, intra-erythrocytic parasites from mice 3 days post-infection were cultured in 
RPMI 1640 medium containing 25 mM HEPES, 0.4% Albumax, 0.2 mM hypoxanthine and 20 µg/mL gentamycin 
at 37 °C with gentle shaking (54 rpm) for 20 h. Infected erythrocytes were separated from non-infected cells on a 
60% Nycodenz column (27.6% w/v Nycodenz in 5 mM Tris-HCl pH 7.20, 3 mM KCl, 0.3 mM EDTA).
Generation of transgenic P. berghei parasites. PbpTKL was disrupted by double crossover homolo-
gous recombination following the introduction of the plasmoGEM vector PbGEM-342364 (Wellcome Sanger 
Institute56) into PbGFP ANKA parasites (kind gift from O. Silvie, Université Pierre et Marie Curie, Paris, France) 
by transfection. The PlasmoGEM construct was linearized using NotI before transfection.
C-terminal AID-HA-tagged PbpTKL strains were generated by single homologous recombination. A 1126-bp 
region of PbpTKL starting 3664 bp downstream from the start codon and lacking a stop codon was prepared 
using primers F28/R29 and F31/R32 (Supplementary Table S1) and inserted upstream of the AID-HA sequence 
in pG362 before the transfection of P. berghei ANKA strain pG230 (both the plasmid and parasite strain were 
kind gifts from N. Philip (The University of Edinburgh, Edinburgh, UK). The targeting sequence was linearized 
using BsaBI before transfection.
Transfections were carried out as previously described100. Briefly, Nycodenz-enriched schizonts were electro-
porated with 5–10 µg of linearized DNA and immediately intravenously injected into naive mice. Transfectants 
were selected using pyrimethamine because the PbGEM-342364 and pG362 vectors both contain a dhfr/ts expres-
sion cassette (Supplementary Fig. S7). From day 1 post-infection, 10 mg/L pyrimethamine (Sigma-Aldrich) was 
supplied in the drinking water. Drug selection was carried out by repeated passages in mice. Transgenic parasites 
were cloned by limiting dilution.
Genotypic analysis of mutants. C-terminal AID-HA-tagged PbpTKL parasites were identified by diag-
nostic PCR using primers F30/Ext and GU533/R3′ (Supplementary Fig. S7a). Immunoprecipitation followed by 
western blot analysis confirmed the expression of a correctly-sized PbpTKL-AID-HA protein. Knockout parasites 
were identified by diagnostic PCR as shown in Supplementary Fig. S7b. Primers GT/GW1 were used to confirm 
integration and primers F5′/R5′ were used to confirm the deletion of PbpTKL. Finally, RT-PCR was used to deter-
mine the PbpTKL transcription status of the mutants (Supplementary Table S1 and Fig. S7).
Lysis of infected erythrocytes. P. berghei-infected erythrocytes directly isolated from infected mouse 
blood or overnight-matured schizonts, treated or not with 5 µg/mL BFA (Sigma-Aldrich) for 6–20 h, were 
Nycodenz-enriched. Two lysis protocols were used.
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For total lysis, a 500-µL dry erythrocyte pellet was lysed in 5 mL ice-cold total lysis buffer (50 mM Tris pH 
7.5, 100 mM NaCl, 1 mM DTT, 1% Triton X-100, 0.5 mM EDTA, 0.2 U/mL DNase, Roche cOmplete EDTA-free 
anti-protease cocktail) for 5 min. The resulting lysate was fractionated by ultracentrifugation (41,657 g, 4 °C, 
15 min) and the supernatant was used for immunoprecipitation.
For sequential lysis, a 500-µL dry pellet was lysed in 3 mL of EQT buffer (20 mM Tris pH 7.4, 130 mM NaCl, 
1 mM MgSO4, 6 µg/mL EQT) on wheel for 15 min at room temperature. After centrifugation, the supernatant was 
fractionated by ultracentrifugation as above to recover ghosts. The EQT lysate ultra-supernatant (corresponding 
to the erythrocyte cytosol) was kept on ice for further analysis. The ghosts were lysed in ice-cold Triton buffer 
(20 mM Tris pH 8.0, 50 mM NaCl, 9% Triton X-100, 5 mM EDTA, Roche cOmplete EDTA-free anti-protease 
cocktail). The pellet, composed of parasites embedded in their parasitophorous vacuole, was further lysed in 3 mL 
of 0.07% saponin (on ice for 10 min). After centrifugation, the supernatant (the parasitophorous vacuole content) 
was kept for further analysis while the parasite pellet was lysed in 2 mL of ice-cold Triton buffer. Saponin, parasite 
and ghost lysates were diluted in total lysis buffer to 5 mL and fractionated by ultracentrifugation as above prior 
to immunoprecipitation (Supplementary Fig. S8).
Immunoprecipitation assay. Lysates prepared as described above were incubated for 1 h rotating on wheel 
at 4 °C with 20–30 µL HA-agarose beads (Invitrogen). The beads were washed three times in ice-cold washing 
buffer (20 mM Tris pH 7.5, 150 mM NaCl, 0.5% Triton X-100) and resuspended in Laemmli sample buffer for 
western blot analysis and/or mass spectrometry.
Mass spectrometry. PbpTKL-AID-HA was immunoprecipitated from ghosts during the trophozoite 
stages and from parasite + parasitophorous vacuole fractions during the schizont stages. Total lysis of the P. 
berghei pG230 strain trophozoites was followed by anti-HA immunoprecipitation to generate wild-type sam-
ples. The presence of PbpTKL-AID-HA in the ghost and schizont samples but not the wild-type samples was 
confirmed by western blot. Three biological replicates of each sample were analyzed by mass spectrometry. The 
detailed NanoLC-MS/MS protein identification and quantification protocol is provided in the Supplementary 
Information. Raw mass spectrometry data have been deposited in the ProteomeXchange Consortium via the 
PRIDE partner repository101 with the dataset identifier PXD011986.
The MS data files were processed using MaxQuant v1.5.8.3 and searched using the Andromeda search engine 
against the Mus musculus database from Swissprot 07/2017 and Plasmodium berghei ANKA from PlasmoDB 
(v37). The PbpTKL-AID-HA chimeric protein sequence was also integrated. Parent mass and fragment ions were 
searched with initial mass deviations of 4.5 and 20 ppm, respectively. The minimum peptide length was set to 
seven amino acids and strict specificity for trypsin cleavage was required, allowing up to two missed cleavage sites. 
Carbamidomethylation (Cys) was set as a fixed modification, whereas oxidation (Met) and N-terminal acetyla-
tion were set as variable modifications. The false discovery rates (FDRs) at the protein and peptide level were set 
to 1%. Scores were calculated in MaxQuant as previously described102. The reverse and common contaminant 
hits were removed from the MaxQuant output. Proteins were quantified according to the MaxQuant label-free 
quantitation (LFQ) algorithm102,103. Matches between runs were not allowed. Wild-type and PbpTKL-AID-HA 
IP biological replicates were analyzed using Perseus v1.6.2.3. The LFQ data were log2 transformed and proteins 
identified in at least two of three PbpTKL-AID-HA replicates but never in the wild-type samples were considered 
“significant”. The data were represented on a volcano plot following the imputation of missing values by creating 
a Gaussian distribution of random numbers with a standard deviation of 30% relative to the standard deviation 
of the measured values and a 4 (wild-type) or 1.8 (PbpTKL-AID-HA) standard deviation downshift of the mean.
Phenotypic analysis of transgenic P. berghei parasites. Mice were infected by the intraperitoneal 
administration of either cryopreserved clones or infected erythrocytes from mice carrying either the wild-type or 
mutant parasites. Parasitemia and gametocytemia were monitored every day up to 7–8 days using Giemsa-stained 
blood smears. To follow the intra-erythrocytic cycle, infection was synchronized by intravenously injecting 
Nycodenz-enriched schizonts into mice99. Blood was collected by cardiac puncture after 3–4 h (typically 0.5–1.2% 
parasitemia was observed) and cultured at 37 °C shaking at 54 rpm for 48 h. Parasite intra-erythrocytic devel-
opment was followed using Giemsa-stained smears at precise time points and compared to wild-type cultures. 
Exflagellation assays were performed 3–4 days after synchronized infection in mice treated with phenylhydrazine 
2 days before infection (4 mg/mouse). Following the assessment of gametocytemia, 10 µL of infected blood was 
added to 50 µL of ookinete medium (RPMI1640 containing 25 mM HEPES and 10% fetal calf serum, pH 8)99 at 
21 °C. Exflagellation centers were counted 15 min post-activation by light microscopy (at least 10 fields).
Inducible knockdown of P. berghei pTKL. The degradation of PbpTKL-AID-HA in the presence of 
3-indoleacetic acid (IAA, Sigma-Aldrich) was first analyzed by western blot. Nycodenz-enriched infected 
erythrocytes, with or without exposure to 0.5 µM IAA for 30 min at 37 °C, were lysed (total lysis protocol) and 
PbpTKL-AID-HA was immunoprecipitated. After confirming protein degradation in the presence of IAA, the 
intra-erythrocytic cycle was studied in vitro as described above, except that rings were cultured with or without 
0.5 µM IAA57.
Immunofluorescence assays and microscopy. P. berghei parasites were synchronized as described 
above. Infected erythrocytes were collected at each development stage and fixed (4% paraformaldehyde and 
0.075% glutaraldehyde in PBS) for 10 min on ice. Following incubation on poly-L-lysine-coated coverslips over-
night at 4 °C, infected erythrocytes were blocked and permeabilized (1% BSA and 0.5% Triton X-100 in PBS) for 
30 min at room temperature. Coverslips were incubated with rabbit anti-HA antibodies (diluted 1:150 in 1% BSA 
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in PBS) and TER119 (diluted 1:500 as above) for 1 h at 37 °C. Coverslips were then incubated with Hoechst 33342 
diluted 1:500 (Sigma-Aldrich) and secondary highly-cross-adsorbed anti-rabbit-AF594 and anti-rat-AF647 
(diluted 1:1000 as above) for 30 min at 37 °C. The samples were mounted in Mowiol 4–88 (Sigma-Aldrich). 
Images were obtained at room temperature with a 63 × Plan Apochromat (1.4 NA) oil objective on the LSM880 
confocal microscope (Zeiss) and processed using Zen Software.
Statistical analysis. The Mann-Whitney U test for non-parametric data was used for statistical compari-
sons of ATP consumption (in vitro Kinase Glo assay), percentages of GVBD observed in Xenopus oocytes and 
phenotypic analyses performed with P. berghei parental and pGEM lines. p < 0.001 was considered significant.
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article and its sup-
plementary materials. Raw mass spectrometry data are openly available on PRIDE repository (ProteomeXchange 
Consortium, PXD011986). Data that support the findings of this study are available from the corresponding 
author CP upon reasonable request.
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